
Sign up to save your podcasts
Or


Prof. Yves Henrotin returns to "Let's Talk OA" today to discuss SYSADOAs, their safety profile and efficacy. As we learned in the previous episode, NSAIDs can raise various concerns when intake is maintained as a long-term treatment, so listen along to continue the conversation on valuable data and clinical experience to gather another expert's point of view regarding mid to long term treatment alternatives.
By Laboratoires ExpanscienceProf. Yves Henrotin returns to "Let's Talk OA" today to discuss SYSADOAs, their safety profile and efficacy. As we learned in the previous episode, NSAIDs can raise various concerns when intake is maintained as a long-term treatment, so listen along to continue the conversation on valuable data and clinical experience to gather another expert's point of view regarding mid to long term treatment alternatives.